News Release

Special supplement to Journal of Clinical Pharmacology features latest NIDA research on marijuana

Peer-Reviewed Publication

NIH/National Institute on Drug Abuse

The November issue of the Journal of Clinical Pharmacology will feature a Special Supplement on Clinical Consequences of Marijuana Use. While most studies deal with the psychosocial consequences of marijuana use, this supplement focuses on the clinical consequences of marijuana use.

The supplement is comprised of papers presented at a workshop held last year by the National Institute on Drug Abuse (NIDA). Research reported there suggests that marijuana use has many subtle effects on the body¡¦s major systems, including temporary impairment of cognitive function, increased heart rate, increased prevalence of chronic cough and acute bronchitis, lower sperm count, and increased neurobehavioral abnormalities for children exposed in utero.

It is estimated that almost 14 million Americans, or 6.3 percent of the population age 12 or older, admit to illegal drug use, with marijuana being the most commonly used illicit drug.

WHAT IT MEANS: The research reported in this supplement describes how marijuana affects nearly every organ system in the body. These findings add to the evidence that marijuana use is associated with significant health hazards.

###

The special supplement was edited by guest editors Jag H. Khalsa, PhD, Sander Genser, MD, MPH, and Henry Francis MD, all from NIDA's Center on AIDS and Other Medical Consequences of Drug Abuse (CAMCODA), and Billy Martin, PhD, of Virginia Commonwealth University.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.